The 4-day response of C3H/HeJ mice to sheep erythrocytes was suppressed by a lipid-free teichoic acid with an average molecular weight of 2,900 when it was administered by the intraperitoneal route. Enhancement was not observed at that time, and neither suppression nor enhancement could be demonstrated by the intravenous route. Either suppression or enhancement of background plaques could be induced, depending upon the timing. Dosage influenced the degree of suppression from 8 to 100 jtg, whereas suppression of background plaques required only 1 ,tg of lipid-free teichoic acid. The kinetics of the sheep erythrocyte response was altered by treatment of the mice with lipid-free teichoic acid, delaying the peak until day 5 and producing enhancement at that time. Although lipid-free teichoic acid was shown to be toxic for mouse splenocytes (50% lethal dose, ca. 200 Mug) in vitro, no effect at the levels employed was observed in vivo. The data presented indicate that modulatory activity is influenced by route, timing, dosage, and apparently the number of antibody-secreting cells.
Enhancement or suppression of unrelated immune responses by a variety of bacterial (as well as nonbacterial) substances is a well-established phenomenon (reviewed in reference 23); however, the mechanisms of action are essentially unknown. With several of these modulators, such as lipopolysaccharide (LPS) (13) and dextran (3) , it has been shown that the direction of the effect (enhancement or suppression) is influenced by dosage, route, and time of administration.
Speculation regarding mechanism has been directed toward various aspects of the modulatory molecule, including cellular binding site, toxicity, and the importance of a lipid component. Some of these substances, such as LPS and streptococcal exotoxin (17), are toxic. Others, such as dextran, are nontoxic. Most work toward identification of target cells has been done with LPS. Employing C3H/St mice, Skidmore et al. (25) have shown that both B lymphocytes and macrophages are involved in immunomodulation by LPS. A requirement for lipid (lipid A) has been demonstrated (6) for enhancement of immune responses by LPS, but obviously lipid is not required for action by other substances, such as dextran. Thus, it appears that there are differences in binding or target site between modulators in which lipid is important and those in which it is not a component. A fatty acid requirement has been reported for suppression of sheep erythrocyte (SRBC) responses in C3H/HeJ mice by a glycerol teichoic acid (GTA) extracted from Streptococcus pyogenes (20, 21) ; however, under the conditions of those experiments, no enhancement was observed. We have recently shown (7) that purified GTA from a Bacillus sp. (ATCC 29726), even though lacking covalently bound fatty acids, can adsorb to cell membranes. Since this membranebinding activity may be involved in the mechanism of immunomodulation, we examined the effect of this purified lipid-free teichoic acid (LFTA) on responses to SRBC.
(A preliminary report of portions of this work was presented at the 61st Annual Meeting of the Federation of American Societies for Experimental Biology, Chicago, Ill., 1 to 8 April 1977.) MATERUILS AND METHODS Animals. Female C3H/HeJ mice and Swiss mice were purchased from Jackson Laboratories, Bar Harbor, Maine, and were maintained in plastic cages on the usual food (Laboratory Animal Chow 5010, Ralston-Purina Co., St. Louis, Mo.). They were 10 to 12 weeks of age when examined.
Teichoic acid. Lipid-containing teichoic acid (LCTA) was prepared by extraction with an equal volume of 95% aqueous phenol from Bacillus sp. ATCC 29726 and was purified as described by Decker et al. (9) . Briefly, it was dialyzed, lyophilized, and dissolved in phosphate-buffered saline. This solution was treated with ribonuclease (type III-B, Sigma IMMUNOMODULATION BY LIPID-FREE TEICHOIC ACID 263 Chemical Co., St. Louis, Mo.), and the protein was precipitated with cold trichloroacetic acid, after which GTA was precipitated from the supernatant with ethyl alcohol. Contaminants were removed by separation on a Sephadex G-100 column, followed by passage through a Bio-Rad 50W X4 (H' form) cation-exchange resin, using 0.1 M acetate buffer. The eluate was dialyzed against water and lyophilized. LFTA was prepared from the LCTA by extraction (four times) with chloroform-ether (3:1) and drying under a stream of nitrogen gas. This was possible because LCTA prepared by the above method is stripped of any covalently bound fatty acids (7) .
Chemical analyses. Hexose was assayed by the anthrone method (27) , hexosamine was assayed by the method of Boas (4), pentose was assayed by the method of Dische (10) , and ribose (ribonucleic acid) was assayed by the orcinol-FeCl3 test. Sugars were also identified by gas-liquid chromatography (1). Phosphorus determinations followed the procedure of Chen et al. (5) , and glycerol was determined by the glycerol dehydrogenase assay (16) . Amino acids were identified and quantitated on an amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.), and fatty acids were identified and quantitated by highpressure liquid chromatography, using the method of Durst et al. (12) , as previously described in detail (7) . Briefly, samples were saponified with methanol, neutralized, and evaporated to dryness under nitrogen gas. Residues were suspended in pyrogen-free water, acidified (pH 2), and extracted with chloroform-ether. The extracts were dried and acidified with 1 N alcoholic HCl, and potassium salts of the fatty acids were formed with 1 (21) , based on the phosphate content of each. On day 3, mice were injected by the same route with 0.5 ml of a 10% suspension of washed SRBC in phosphate-buffered saline. A control group received phosphate-buffered saline in lieu of GTA, and a second control group received GTA but no SRBC. At 4 days after SRBC injection, all animals were sacrificed and their splenocytes were examined by the hemolytic plaque assay.
Further experiments were designed to determine the effects of timing and dosage on modulation by LFTA. The former protocols were designed as described above, except the total dose of LFTA (8 jig) was given on either day 1, 2, or 3 of the experiment. The latter protocols were similar in design, except they included groups of mice given various doses of LFTA ranging from 0 to 100 l g and each dose was given i.p. 2 days before injection of SRBC.
The effect of LFTA on the kinetics of the SRBC response was also studied. In these experiments, 10 ,ug of LFTA was given 2 days before injection of SRBC, and the hemolytic plaque response was assayed on days 1 to 9 postinjection of SRBC.
Hemolytic plaque test. For the hemolytic plaque test, the technique of Jerne and Nordin (18) (Fig. 1) . After chloroform-ether extraction, no fatty acids could be detected (Fig. 2) , indicating that those demonstrated before extraction were not covalently bound in the purified material. This prep-VOL. 26, 1979 aration is referred to as LFTA. Limulus amoebocyte lysate tests indicated that the preparation was free of LPS contamination (procedure detects as little as 0.05 ng/ml, whereas 5 ng/ml failed to induce suppression).
In initial experiments employing 8 ,ug of LFTA per mouse by the i.p. route, significant (P < 0.005) suppression of the SRBC response (59%) was demonstrated (Table 3 ). This suppression was observed repeatedly. Under the same conditions, 50 ,ug of LPS was required to produce 71% suppression. The difference between suppression by LCTA and LFTA was not significant, indicating that fatty acids are not essential for modulation. In parallel experiments, injection of either teichoic acid preparation by the intravenous route failed to produce any modulatory effect.
To determine whether the time that elapsed between injection of LFTA and SRBC influenced modulation, we injected C3H/HeJ mice i.p. with 8 jig of purified LFTA in three subdoses or in single doses on various days before immunization. There was no significant difference between suppression in animals receiving the LFTA in three doses over a 3-day period and those receiving it as a single dose at 1 or 2 days before immunization (Table 4) . However, when LFTA was given shortly before SRBC on the same day, there was no effect on the response. In unimmunized mice, the SRBC background plaques (PFC) were significantly suppressed also when LFTA was given 1 or 2 days before SRBC, but were enhanced when it was given on the same day as SRBC.
In view of these results, we performed doseresponse experiments employing LFTA treatment by the i.p. route at 2 days before SRBC immunization. As shown in Table 5 , suppression occurred at doses of 10 Fig. 4 . The mean viability for C3H/HeJ splenocytes was 78% of the control at 50 ,g of LFTA per culture and 51% of the control at 200 ,ug of LFTA per culture (P < 0.01). These data were obtained in 4-day cultures, although toxicity was also demonstrated at 3 days. In the earlier experiments referred to above, LFTA was also toxic for rat splenocytes. Mobile phases: (A) 90% methanol-10% water; (B) 95% methanol-6% water; (C) absolute methanol. Peaks were identified by internal standards as a-p-dibromoacetophenone (peaks 1, 3, and 8), laurie derivative (2 and 4), myristic derivative (5), palmitic derivative (6) , and steric derivative (7).
lation (24) has been reported, and it has been suggested that lipid is also essential for several biological activities of teichoic acids (31 water; (C) absolute methanol. The three peaks were identified by internal standards as a-p-dibromoaceto- Our GTA was free of LPS, whereas it has been shown that LPS is ubiquitous in distilled water (7) and commercial preparations (11) . Elimination of LPS is important because, although immune responses, adjuvant effects, and mitogenic activity by LPS in C3H/HeJ mice are limited (28), suppression has been reported recently (15) , and it also has been shown that LPS contains mitogenic agents which are effective in C3H/HeJ mice (14, 32) . Since there is a possibility of synergistic or antagonistic effects by small quantities of contaminating LPS or other mitogens and since the presence or absence of associated mitogenic agents in environmental LPS has not been determined, it was desirable to eliminate the substance. In view of the foregoing, the chance of biological activity by contaminants was much greater in the work of (20) , that the fragments may repolymerize and regain activity under ill-defined conditions. Thus, the loss and recovery of modulatory activity could have been due to changes in chain length.
Since the GTA molecule under study consists essentially of a stripped polyglycerophosphate backbone (9) which averages 19 glycerol residues in length (7), it appears that a simple repeating polymer of about 2,900 daltons is able to induce modulatory activity. This picture differs from that of LPS, but is reminiscent of similar activities by dextran (3), although the latter polymer is considerably larger. An even smaller molecule, muramyl dipeptide (500 daltons), has been shown to modulate immune responses (26) .
The present investigation shows that apparent suppression by LFTA in assays made 4 days after SRBC injection was actually due to a delay in the peak response of an enhanced reaction. The fact that Miller and Jackson (20) (19) . Our data suggest that a kinetic shift may be an important aspect of some modulatory mechanisms. It appears, however, that this shift alone does not explain the phenomenon, since significant enhancement occurred as well. The present results demonstrate that PFC assays made 4 days after SRBC injection will not detect maximal responses that are modulated by LFTA, even though they do detect maximal responses in controls. This complicates the interpretation and experimental design, suggesting that such observations should be made over a period of 7 days.
Although we have shown that LFTA is toxic for mouse splenocytes in vitro, the amounts needed to achieve this effect were obviously much greater than those employed in these in vivo experiments. Nevertheless, it is possible that the observed modulation involved some selective cytotoxicity, perhaps combined with stimulation of a different cell population.
The time of administration, route, and dosage of LFTA all were shown to affect its modulatory activity, as previously reported for other modulators (3, 13, 23) . The effect of timing was of particular interest because no modulation was produced when LFTA was administered on the same day as SRBC, although the same dosage was effective when given 1 or 2 days before. It would seem that action by LFTA to delay and enhance the peak immune response requires considerable time. However, enhancement of background PFC occurred 4 days after LFTA treatment, indicating more rapid kinetics. Since the numbers of antibody-secreting cells were more than 2 orders of magnitude lower in these animals, the kinetics would be expected to differ in this way. The importance of dosage was also demonstrated by the fact that a smaller dose was required for suppressing background PFC than for suppressing the greater numbers of PFC in immunized mice.
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